Wikipedia

Integra LifeSciences

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey.[3][4] Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery.[3] Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.[5][6]

Integra LifeSciences Holdings Corporation
IART
Company typePublic
IndustryMedical technology
Founded1989; 35 years ago (1989)[1]
HeadquartersPrinceton, New Jersey, U.S.
Key people
Jan De Witte (CEO)[2]
Products
RevenueUS$1.3 billion (2020)[1]
Number of employees
approx. 3,946 (Dec. 2023)
Websiteintegralife.com

History

edit

Integra LifeSciences was founded by Richard Caruso in 1989 after Caruso licensed Integra artificial skin technology from Harvard–MIT and acquired Colla-tec, a subsidiary of Marion Laboratories.[3][7] The company became publicly traded under the NASDAQ ticker name IART.[7]

In 1996, Integra artificial skin was approved by the U.S. Food and Drug Administration.[8] The artificial skin, manufactured and patented as Integra, is now used on patients with extensive burns.[5] In 1999, the FDA approved Integra LifeSciences’ DuraGen, an absorbable implant used in neurosurgical and spinal procedures.[9]

In 2001, NMT, a company acquired by Integra in 2002,[10] received FDA approval for Licox, a brain tissue oxygen and temperature monitor.[11][12] Licox is used to treat patients in critical care, including those suffering from traumatic brain injuries.[11]

In 2002, the FDA approved the use of Integra Dermal Regeneration Template for reconstructive surgery of burn scars.[13] In 2016, IDRT received premarket approval from the FDA for the treatment of diabetic foot ulcers.[14]

In 2018, Integra LifeSciences was included in Fortune’s list of Fastest Growing Companies.[15]

In 2023, Integra ranked #59 on Medical Design and Outsourcing’s list of largest medical technology companies in the world.[16]

Integra artificial skin

edit

In 1969, John F. Burke, a surgeon and Harvard Medical School professor, and Ioannis V. Yannas, a mechanical engineering professor of fibers and polymers at MIT, began working on a new form of artificial skin.[5] They created the first commercially reproducible artificial skin, later patented and manufactured as Integra.[5]

Integra is used to treat patients with severe burns.[5][6][8] The top layer, made of thin silicone, protects the patient from infection and dehydration, common causes of death after being severely burned.[5][8] The bottom layer, made of animal tissue, acts as scaffolding where new skin will grow.[5][17] Compared to traditional skin grafts, the use of Integra reduces pain and scarring.[5][8][17][6]

Integra is also used in plastic surgery, reconstructive surgery, and to treat some forms of cancer and other skin wounds.[6][18][19][20]

Acquisitions

edit

In October 2014, Integra LifeSciences acquired instrumentation lines from Medtronic for $60 million.[21] In January 2014, the company bought Covidien’s Confluent Surgical line of sealants and shields.[22]

In July 2015, Integra LifeSciences acquired TEI Biosciences and TEI Medical and began manufacturing their SurgiMend and PriMatrix product lines.[23][24] Primatrix, a dermal repair scaffolding product, is used to treat diabetic foot ulcers, burns, and in other procedures.[25][26]

In January 2017, Integra Lifesciences acquired Derma Sciences for $204 million.[27] Their TCC-EZ Total Contact Cast, used to treat diabetic foot ulcers, reduces pressure and shortens application time compared to a conventional total contact cast.[27][28][29]

In October 2017, Integra LifeSciences acquired Johnson & Johnson’s Codman Neurosurgery business for $1.045 billion.[30] The Codman Hakim valve was developed as a new way to treat hydrocephalus.[31][32]

In January 2021, the company acquired regenerative medicine firm, ACell, for $400M.[33][34]

References

edit
  1. ^ a b https://investor.integralife.com/static-files/2b15533d-3c34-4583-991c-86139e821468 [bare URL PDF]
  2. ^ "Integra Lifesciences announces new CEO". 28 October 2021.
  3. ^ a b c Trenton, Joyce J. Persico | For The Times of (2011-09-30). "Integra upgrades Plainsboro office for skin regeneration market". nj. Retrieved 2021-10-12.
  4. ^ "Integra LifeSciences Celebrates New Global Headquarters". New Jersey Business Magazine. Retrieved 2021-10-12.
  5. ^ a b c d e f g h Vitello, Paul (2011-11-05). "Dr. John F. Burke, Dies at 89; Created Synthetic Skin". The New York Times. ISSN 0362-4331. Retrieved 2021-10-08.
  6. ^ a b c d "New healing, hope for burn victims | The Seattle Times". archive.seattletimes.com. Retrieved 2021-10-08.
  7. ^ a b Crosby, John C. (2019-06-13). Built to Help Each Other: Mentoring in the Life of Richard Caruso: An Uncommon Man. Radius Book Group. ISBN 978-1-63576-708-7.
  8. ^ a b c d Schaffer, Amanda (2006-05-02). "Cadaver Skin Fills the Gap in Burn Cases". The New York Times. ISSN 0362-4331. Retrieved 2021-10-14.
  9. ^ "Integra Lifesciences Cleared to Market New Dural Graft Matrix". www.meddeviceonline.com. Retrieved 2021-10-14.
  10. ^ https://investor.integralife.com/news-releases/news-release-details/integra-lifesciences-acquires-neurosciences-division-nmt-medical
  11. ^ a b Stewart, Campbell (December 1, 2008). "The New Licox Combined Brain Tissue Oxygen and Brain Temperature Monitor". Neurosurgery. 63 (6): 1159–1165. doi:10.1227/01.NEU.0000333265.19131.7C. PMID 19057329. S2CID 33380827 – via Oxford Academic.
  12. ^ Layon, Joseph A.; Gabrielli, Andrea; Friedman, William A. (2013). Textbook of Neurointensive Care. Springer. p. 135. ISBN 978-1-4471-5225-5.
  13. ^ "FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers". FDA. 2018-11-03. Retrieved 2021-10-14.
  14. ^ "Premarket Approval (PMA)". www.accessdata.fda.gov. Retrieved 2021-10-14.
  15. ^ "Inside Fortune's 2018 Fastest-Growing Companies List". Fortune. Retrieved 2022-03-01.
  16. ^ "The 2023 Medtech Big 100: The world's largest medical device companies". Medical Design and Outsourcing. Retrieved 2023-09-03.
  17. ^ a b FDA Consumer 2002-06: Vol 36 Iss 3. Superintendent of Documents. June 2002.
  18. ^ Thinda, Sumeer; Wright, Harry V.; Mawn, Louise A. (February 2012). "Integra Bilayer Matrix Wound Dressing Closure of Large Periorbital Traumatic Wound". Arch Ophthalmol. 130 (2): 217–219. doi:10.1001/archopthalmol.2011.1178. PMID 22332215 – via JAMA Network.
  19. ^ Chang, Daniel K.; Louis, Matthew R.; Gimenez, Alejandro; Reece, Edward M. (August 2, 2019). "The Basics of Integra Dermal Regeneration Template and its Expanding Clinical Applications". Seminars in Plastic Surgery. 33 (3): 185–189. doi:10.1055/s-0039-1693401. PMC 6680073. PMID 31384234.
  20. ^ Chalmers, R L; Smock, E; Geh, J L C (March 23, 2010). "Experience of Integra(®) in cancer reconstructive surgery". Journal of Plastic, Reconstructive & Aesthetic Surgery. 63 (12): 2081–2090. doi:10.1016/j.bjps.2010.02.025. PMID 20335086 – via National Library of Medicine.
  21. ^ "Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic". MassDevice. October 27, 2014.
  22. ^ "Covidien closes $235M divestiture of Confluent to Integra LifeSciences". MassDevice. January 16, 2014. Retrieved 2022-01-19.
  23. ^ "Integra LifeSciences Completes Acquisition Of TEI Biosciences, TEI Medical". www.meddeviceonline.com. 2015-07-20. Retrieved 2022-02-22.
  24. ^ "510(k) Premarket Notification". www.accessdata.fda.gov. Retrieved 2022-02-22.
  25. ^ Karr, Jeffrey (2011). "Retrospective Comparison of Diabetic Foot Ulcer and Venous Stasis Ulcer Healing Outcome Between a Dermal Repair Scaffold (PriMatrix) and a Bilayered Living Cell Therapy (Apligraf)". Advances in Skin & Wound Care. 24 (3): 119–125. doi:10.1097/01.ASW.0000395038.28398.88. PMID 21326023. S2CID 26391378.
  26. ^ Parcells, Alexis Lanteri; Karcich, Jenika; Granick, Mark S.; Marano, Michael A. (2014-09-24). "The Use of Fetal Bovine Dermal Scaffold (PriMatrix) in the Management of Full-Thickness Hand Burns". ePlasty. 14: e36. ISSN 1937-5719. PMC 4182964. PMID 25328569.
  27. ^ a b Hodsden, Suzanne (2017-01-13). "Integra LifeSciences Acquirers Derma Sciences for $204M, Expands Regenerative Technology Offerings". www.meddeviceonline.com. Retrieved 2022-02-17.
  28. ^ Arnold, Jonathan F.; Marmolejo, Valerie (October 2017). "Outcomes Achieved With Use of a Prefabricated Roll-On Total Contact Cast". Foot & Ankle International. 38 (10): 1126–1131. doi:10.1177/1071100717716486. ISSN 1944-7876. PMID 28800712. S2CID 40470722.
  29. ^ Messenger, Grace; Masoetsa, Richard; Hussain, Imtiaz (2018-06-07). "A Narrative Review of the Benefits and Risks of Total Contact Casts in the Management of Diabetic Foot Ulcers". The Journal of the American College of Clinical Wound Specialists. 9 (1–3): 19–23. doi:10.1016/j.jccw.2018.05.002. ISSN 2213-5103. PMC 6304285. PMID 30591897.
  30. ^ Newmarker, Chris (2017-10-02). "Integra LifeSciences completes purchase of J&J's Codman Neurosurgery". MassDevice. Retrieved 2022-02-09.
  31. ^ Gunderman, Richard; Lopez, Gloria (2019-01-17). "Who was Hakim?" (PDF). Journal of Radiology and Medical Imaging. ISSN 2637-885X – via MEDDOCS Open Access Publisher.
  32. ^ Sussman, Ph.D, Marvin (2011-05-09). "Dr. Salomon Hakim – a Giant in the Field of Hydrocephalus". Hydrocephalus Association. Retrieved 2022-02-09.
  33. ^ "Integra LifeSciences to acquire ACell". MassDevice. 2020-12-16. Retrieved 2022-01-12.
  34. ^ "Integra (IART) Acquires Acell, Focuses on Regenerative Space". Nasdaq. January 21, 2021.
edit
  • Official website
  • Business data for Integra LifeSciences Holdings Corporation:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Integra_LifeSciences&oldid=1232311571"